Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Classification of erythermalgia]

H Levesque1

  • 1Service de Médecine Interne-Angiologie, CHU Rouen-Boisguillaume.

Journal Des Maladies Vasculaires
|January 1, 1996
PubMed
Summary

Erythromelalgia and erythermalgia are distinct conditions. Effective treatment requires distinguishing between primary erythermalgia, secondary erythermalgia linked to thrombocythaemia, and other secondary causes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patients.

Thrombosis research·2024
Same author

[Acquired hemophilia and pregnancy: A necessarily multidisciplinary approach].

La Revue de medecine interne·2022
Same author

[Identification of factors associated with performance in objective structured clinical examination in Rouen medical school].

La Revue de medecine interne·2022
Same author

Characterizing hospital pathways for the care of acquired hemophilia in France using comprehensive national health data.

La Revue de medecine interne·2021
Same author

Systematic screening for a proximal DVT in COVID-19 hospitalized patients: Results of a comparative study.

Journal de medecine vasculaire·2021
Same author

Refractory severe idiopathic systemic capillary leak syndrome successfully treated with bevacizumab: a case report.

Angiogenesis·2021

Area of Science:

  • Vascular Medicine
  • Dermatology
  • Rheumatology

Context:

  • Erythermalgia and erythromelalgia are often confused, leading to diagnostic challenges.
  • Existing classifications for erythermalgia lack clarity regarding distinct etiologies.
  • Accurate differentiation is crucial for targeted and effective therapeutic strategies.

Purpose:

  • To clarify the distinction between erythromelalgia and erythermalgia.
  • To propose a refined classification system for erythermalgia based on etiology.
  • To guide clinical management by differentiating subtypes of erythermalgia.

Summary:

  • Erythromelalgia and erythermalgia are identified as separate disease entities.
  • A three-type clinical classification is proposed: erythromelalgia in thrombocythaemia, primary erythermalgia, and secondary erythermalgia.
  • A study of 19 erythermalgia cases revealed 9 primary (6 aspirin-responsive) and 10 secondary (5 myeloproliferative disorders, 2 SLE, 3 drug-induced).
  • A two-level classification is suggested: primary vs. secondary, with further sub-categorization for familial/non-familial primary and specific causes of secondary erythermalgia.

Impact:

  • Provides a clearer diagnostic framework for differentiating erythermalgia subtypes.
  • Facilitates the selection of appropriate treatments based on underlying causes.
  • Improves patient outcomes by enabling targeted therapeutic interventions.

Related Experiment Videos